Study objectives: To evaluate the outcomes of a nurse- led, HCV education, testing, and linkage-to-care program located at the BCCfE’S Hope to Health (H2H) supervised consumption site in the Downtown Eastside of Vancouver.
STUDIES MENU
Activities
Offer rapid HCV testing in a low-barrier supervised consumption site to all clients
conduct interviewer administered questionnaire at baseline and 6-month follow up to assess self reported substance use patterns, engagement with health care, and harm reduction access
characterize health care experiences and outcomes for clients of nurse- led intervention embedded within a community setting frequented by people who use drugs
Start Date
November 2021
Funding Organization (2021-2022)
Scroll to Top
CLICK FOR NEW HIV-1 RESISTANCE GENOTYPE REPORT NOTICE
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’. For more details and example reports, please click on the button below